LGALS9 and COVID-19: The mean plasma Gal-9 concentration in COVID-19 patients was 2250 ng/ml, compared to 450 ng/ml in healthy controls (Iwasaki-Hozumi et al., 2021), and Gal-9 expression is significantly higher in pulmonary tissues than in plasma (Matsumoto et al., 2013).